NOVACYT (ALNOV.PA) Stock Price, Quote, News and Overview
EPA:ALNOV - Euronext Paris - Matif - FR0010397232 - Common Stock - Currency: EUR
ALNOV.PA Quote, Performance and Key Statistics
EPA:ALNOV (3/7/2025, 7:00:00 PM)
0.589
+0.01 (+1.55%)
The current stock price of ALNOV.PA is 0.589 EUR. In the past month the price decreased by -2.48%. In the past year, price increased by 16.4%.
ALNOV.PA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 21.07 | 346.68B | ||
| 1ABBV.MI | ABBVIE INC | 20.82 | 342.48B | ||
| AMG.DE | AMGEN INC | 16.43 | 161.21B | ||
| 1AMGN.MI | AMGEN INC | 15.84 | 160.89B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 25.67 | 135.84B | ||
| GIS.DE | GILEAD SCIENCES INC | 25.39 | 134.40B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 1667.04 | 115.58B | ||
| ARGX.BR | ARGENX SE | 253.61 | 33.75B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 24.36B | ||
| IDP.DE | BIOGEN INC | 9.25 | 20.54B | ||
| 1BIIB.MI | BIOGEN INC | 8.39 | 19.21B | ||
| 0QF.DE | MODERNA INC | N/A | 13.19B |
Related stock screener links
About ALNOV.PA
Company Profile
Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 240 full-time employees. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The firm provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. Novacyt SA offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The firm creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle. Novacyt SA is present in France and internationally through a network of distributors.
Company Info
NOVACYT
13 Avenue Morane Saulnier
Velizy-Villacoublay ILE-DE-FRANCE FR
Employees: 240
Company Website: https://novacyt.com/
Investor Relations: http://www.novacyt.com/investors/
Phone: 33139465104
NOVACYT / ALNOV.PA FAQ
What is the stock price of NOVACYT today?
The current stock price of ALNOV.PA is 0.589 EUR. The price increased by 1.55% in the last trading session.
What is the ticker symbol for NOVACYT stock?
The exchange symbol of NOVACYT is ALNOV and it is listed on the Euronext Paris - Matif exchange.
On which exchange is ALNOV.PA stock listed?
ALNOV.PA stock is listed on the Euronext Paris - Matif exchange.
What is NOVACYT worth?
NOVACYT (ALNOV.PA) has a market capitalization of 41.60M EUR. This makes ALNOV.PA a Nano Cap stock.
How many employees does NOVACYT have?
NOVACYT (ALNOV.PA) currently has 240 employees.
What are the support and resistance levels for NOVACYT (ALNOV.PA) stock?
NOVACYT (ALNOV.PA) has a support level at 0.57 and a resistance level at 0.59. Check the full technical report for a detailed analysis of ALNOV.PA support and resistance levels.
Is NOVACYT (ALNOV.PA) expected to grow?
The Revenue of NOVACYT (ALNOV.PA) is expected to grow by 48.47% in the next year. Check the estimates tab for more information on the ALNOV.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NOVACYT (ALNOV.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALNOV.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALNOV.PA, evaluating the profitability, health, valuation and growth aspects
- NOVACYT (ALNOV.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NOVACYT (ALNOV.PA) Sales and EPS estimates to see what analysts future expectations are.
- NOVACYT (ALNOV.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NOVACYT (ALNOV.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- NOVACYT (ALNOV.PA) Stock Chart to make your own analysis
- NOVACYT (ALNOV.PA) Latest news and press-releases to stay up to date.
Does NOVACYT (ALNOV.PA) stock pay dividends?
ALNOV.PA does not pay a dividend.
What is the Price/Earnings (PE) ratio of NOVACYT (ALNOV.PA)?
NOVACYT (ALNOV.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.63).
ALNOV.PA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ALNOV.PA. When comparing the yearly performance of all stocks, ALNOV.PA turns out to be only a medium performer in the overall market: it outperformed 63.12% of all stocks.
ALNOV.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ALNOV.PA. ALNOV.PA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
ALNOV.PA Financial Highlights
Over the last trailing twelve months ALNOV.PA reported a non-GAAP Earnings per Share(EPS) of -0.63. The EPS decreased by -47.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -37.87% | ||
| ROE | -53.46% | ||
| Debt/Equity | 0.17 |
ALNOV.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 37% to ALNOV.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 8.21% and a revenue growth 48.47% for ALNOV.PA